Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price rose 27.8% during mid-day trading on Tuesday . The company traded as high as $3.25 and last traded at $3.25. Approximately 320 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 1,886 shares. The stock had previously closed at $2.54.
Mayne Pharma Group Price Performance
The business’s 50 day moving average is $2.68 and its 200-day moving average is $3.35.
About Mayne Pharma Group
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Recommended Stories
- Five stocks we like better than Mayne Pharma Group
- Want to Profit on the Downtrend? Downtrends, Explained.
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
